SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001354488-11-003493
Filing Date
2011-09-20
Accepted
2011-09-20 15:34:31
Documents
1
Period of Report
2011-09-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT issuerdirect_section16.html 4  
1 PRIMARY DOCUMENT issuerdirect_section16.xml 4 2949
  Complete submission text file 0001354488-11-003493.txt   4414
Mailing Address 1004 CHAGFORD WAY RALEIGH NC 27614
Business Address 1004 CHAGFORD WAY RALEIGH NC 27614 919-313-4930
CURAXIS PHARMACEUTICAL Corp (Issuer) CIK: 0001434893 (see all company filings)

IRS No.: 261919261 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O CURAXIS PHARMACEUTICAL CORPORATION 1004 CHAGFORD WAY RALEIGH NC 27614
Business Address
Leary Stephen J (Reporting) CIK: 0001524761 (see all company filings)

Type: 4 | Act: 34 | File No.: 333-150937 | Film No.: 111099430